Latest news about Allergy Medication
Merck 2Q Profit Drops 52% On Charges; Sales Rise
Merck 2Q Profit Drops 52% On Charges; Sales Rise
30 Jul 2010, 7:18 am | click here for more
AIDS 2010 Follow-Up Coverage: Global HIV/AIDS Funding; HIV/AIDS Studies, Releases
Media outlets continued to reflect on news from the International AIDS Conference-AIDS 2010, which attracted over 19,000 participants from 197 countries to Vienna last week, according to the conference blog. The Washington Post reports that "concerns about [the] costs" of global HIV treatment programs "dominated the talk" of the conference. The newspaper notes that some HIV/AIDS advocates used ...
30 Jul 2010, 7:05 am | click here for more
Merck Announces Second-Quarter 2010 Financial Results
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP earnings per share for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise.
30 Jul 2010, 5:00 am | click here for more
News briefs
Navy Ball fundraiser Brusters Ice Cream will be selling ice cream in front of the ITT building from 1-2:30 p.m. today, then again on Aug. 5 at the North Engineering middle (Bldg. 2185), also from 1-2:30 p.m. A portion of the proceeds will be donated to this years Navy Ball. arrive like some ice cream and support this celebration of our Navys wealthy heritage.
30 Jul 2010, 1:43 pm | click here for more
Travelling with allergies
ONE minute you are in the pink of health enjoying your meal and, the next, you could be doubled over in pain, utterly confused. If you have a family history of allergy to certain food, it may be wise to take note of what these are.
29 Jul 2010, 10:34 pm | click here for more
Shionogi Inc. Announces FDA Approval of CUVPOSA(TM) for the Treatment of Chronic Severe Drooling in Pediatric Patients ...
FLORHAM PARK, N.J., July 29 /PRNewswire/ -- Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA(TM) (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA(TM) was designated an ...
29 Jul 2010, 10:13 am | click here for more
Practice Fusion Releases Prescription Index, Launches Research Division
Practice Fusion launches its Research Division today with the release of a Prescription Index tracking medication volume by physician specialty. Â Prescriptions for blood pressure , cholesterol , infection and depression topped the four lists. Â Practice Fusion's new Research Division provides the critical information needed to power clinical research for drug interaction monitoring, disease ...
28 Jul 2010, 6:11 am | click here for more
Allergies sticking around
If you think your allergies are worse this year than ever before, you may be right!
28 Jul 2010, 5:14 pm | click here for more
Flexible health care spending rules getting trickier in 2011
Items such as allergy pills and heartburn medication will soon be a little trickier to buy via flexible spending accounts.
27 Jul 2010, 3:42 am | click here for more